Brazilian study maps HER2 in Women's cancers to unlock targeted treatments
NCT ID NCT07101081
First seen Mar 23, 2026 · Last updated May 20, 2026 · Updated 8 times
Summary
This study looks at how often a protein called HER2 is found at high levels in gynecological cancers (like endometrial, ovarian, and cervical cancer). Researchers will test tumor samples from 350 adults in Brazil using special lab methods. The goal is to learn which patients might benefit from HER2-targeted therapies in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GYNAECOLOGICAL CANCERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGSão Paulo, Brazil
Conditions
Explore the condition pages connected to this study.